Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business
Anti-Hypertensive Drugs - A Global Strategic Business Report

Anti-Hypertensive Drugs - A Global Strategic Business Report - new market report released


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2010-03-15 15:01:05 - Anti-Hypertensive Drugs - A Global Strategic Business Report - a new market research report on companiesandmarkets.com

www.companiesandmarkets.com/Summary-Market-Report/anti-hypertens ..

This 893 page report analyzes the worldwide markets for Anti-Hypertensive Drugs in US$ Million. The report provides separate comprehensive analytics for US, Europe and Rest of World. Annual forecasts are provided for each region for the period 2007 through 2015. Also, a six-year historic analysis is provided for these markets

. The report profiles 145 companies including many key and niche players worldwide such as AstraZeneca PLC, AstraZeneca PLC, Biovail Corp, Biovail Corp, Biovail Corp, Daiichi Sankyo Company, Limited, Dr. Reddy´s Laboratories Ltd., Forest Laboratories, Inc., Forest Laboratories, Inc., Merck & Co., Inc., Mylan, Inc., Novartis AG,. Pfizer, Inc., Ranbaxy Laboratories Limited, Sanofi-aventis, Solvay Pharmaceuticals SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Limited, and The Medicines Company. Market

 

 

data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Please see the table of contents for more information and to see tables and graphs contained within the report.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser